BSE Live
Apr 17, 16:01Prev. Close
194.05
Open Price
194.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 17, 15:56Prev. Close
194.48
Open Price
194.90
Bid Price (Qty.)
191.94 (973)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Jagsonpal Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 13.28 | 13.22 | 13.10 | 13.10 | 13.10 | |
| Total Share Capital | 13.28 | 13.22 | 13.10 | 13.10 | 13.10 | |
| Reserves and Surplus | 226.27 | 174.18 | 145.79 | 109.92 | 100.99 | |
| Total Reserves and Surplus | 226.27 | 174.18 | 145.79 | 117.76 | 108.83 | |
| Total Shareholders Funds | 239.55 | 187.40 | 158.89 | 130.86 | 121.93 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 3.07 | 2.07 | 2.16 | 2.19 | 1.86 | |
| Other Long Term Liabilities | 8.30 | 7.56 | 5.25 | 0.00 | 0.00 | |
| Long Term Provisions | 1.04 | 0.92 | 1.08 | 1.26 | 0.02 | |
| Total Non-Current Liabilities | 12.41 | 10.55 | 8.49 | 3.44 | 1.88 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 6.79 | |
| Trade Payables | 9.73 | 7.60 | 16.36 | 16.29 | 18.05 | |
| Other Current Liabilities | 15.16 | 10.78 | 10.83 | 17.38 | 14.71 | |
| Short Term Provisions | 1.01 | 0.75 | 0.38 | 0.49 | 0.85 | |
| Total Current Liabilities | 25.90 | 19.13 | 27.57 | 34.16 | 40.40 | |
| Total Capital And Liabilities | 278.26 | 217.08 | 194.95 | 168.45 | 164.20 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 8.84 | 9.30 | 24.28 | 22.37 | 23.35 | |
| Intangible Assets | 85.62 | 0.00 | 0.00 | 2.38 | 2.38 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 94.45 | 9.30 | 24.28 | 24.75 | 25.72 | |
| Non-Current Investments | 0.00 | 0.00 | 1.12 | 20.58 | 12.06 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 | |
| Other Non-Current Assets | 22.61 | 8.52 | 4.99 | 12.35 | 5.50 | |
| Total Non-Current Assets | 117.07 | 17.82 | 30.39 | 57.68 | 43.73 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 22.14 | 3.25 | |
| Inventories | 15.20 | 15.00 | 20.68 | 29.74 | 29.72 | |
| Trade Receivables | 13.18 | 10.95 | 20.87 | 15.58 | 12.66 | |
| Cash And Cash Equivalents | 128.73 | 147.93 | 114.63 | 26.15 | 60.23 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.31 | 0.27 | |
| OtherCurrentAssets | 4.09 | 25.37 | 8.39 | 16.86 | 14.34 | |
| Total Current Assets | 161.19 | 199.25 | 164.56 | 110.78 | 120.48 | |
| Total Assets | 278.26 | 217.08 | 194.95 | 168.45 | 164.20 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 15.46 | 11.22 | 6.09 | 5.87 | 5.99 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 3.42 | 4.10 | 2.73 | 5.17 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 5.11 | 4.66 | 5.53 | 4.54 | 7.23 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | 1.02 | 20.58 | 12.06 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
22.01.2026
JagsonpalPharma Standalone December 2025 Net Sales at Rs 72.95 crore, down 1.46% Y-o-Y
10.11.2025
JagsonpalPharma Standalone September 2025 Net Sales at Rs 74.47 crore, down 0.3% Y-o-Y
28.07.2025
JagsonpalPharma Standalone June 2025 Net Sales at Rs 75.61 crore, up 23.07% Y-o-Y
07.05.2025
JagsonpalPharma Standalone March 2025 Net Sales at Rs 58.56 crore, up 34.66% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth